Similar to prodrug approach, our linker technology can connect two complementary drug molecules to form novel drug conjugate. By using different linker, the cleave rate can be modified after drug administration. The linkers are hydrolyzed and eliminated from the body as benign water-soluble molecules. These drug conjugates can be:

•  Better Absorption through oral or topical administration
•  Minimize Side Effects
•  Possess ''Dual-Acting'' function which target multiple biological targets